EPidural's Impact on Contractions and Fetal REsponse
EPI-CARE
The Effect of Epidural Analgesia on Uterine Contractility and Intrapartum Fetal Well-being - Study Protocol for a Prospective Observational Study "EPI-CARE"
1 other identifier
observational
200
1 country
1
Brief Summary
This prospective observational study aims to assess the impact of epidural analgesia (ELA) on uterine contractility, cardiotocography (CTG) patterns, and maternal-fetal hemodynamics in term pregnancies. The study will recruit 200 laboring patient receiving ELA and evaluate changes in uterine contractions, Doppler blood flow parameters, and fetal heart rate tracings before and after ELA administration. Secondary analyses will compare outcomes between primiparous and multiparous women, as well as between uncomplicated and complicated pregnancies. Pain relief effectiveness will be correlated with observed changes. This study will provide a comprehensive understanding of ELA's effects on labor progression and fetal well-being, addressing gaps in existing research.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 25, 2025
CompletedFirst Posted
Study publicly available on registry
March 6, 2025
CompletedStudy Start
First participant enrolled
March 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMarch 6, 2025
February 1, 2025
10 months
February 25, 2025
February 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Changes in uterine contractility
Uterine activity will be monitored using the external tocography and expressed as number of contractions per 10 minutes. Due to known limitations of the external tocography the labor progression, defined as the change in cervical dilation between the two vaginal examinations (the patients will be examined just before the administration of epidural analgesia and two hours after) will also be recorded in cm.
From enrollment to 120 minutes after the administration of epidural analgesia
Changes in maternal and fetal doppler velocities
The pulsatility index (PI) of maternal uterine arteries, umbilical artery and fetal middle cerebral artery will be assessed by ultrasound before and 30, 60 and 120 minutes after the administration of epidural analgesia. Additionally, the PI in maternal uterine artery will be measured within first 24 hours after labor.
From enrollment to 24 hours after labor
Changes in cardiotocography (CTG) patterns
CTG patterns will be monitored using the external tocography. The change in CTG patterns after the administration of epidural analgesia will be assessed by experts overlooking the study and they will be labeled as normal, suspicious or pathological using the FIGO guidelines.
From enrollment up to 120 minutes after the administration of epidural
Secondary Outcomes (3)
Differences between primiparous and multiparous patients
From enrollment to 120 minutes after the administration of ELA
Differences between complicated and uncomplicated pregnancies
From enrollment up to 120 minutes after the administration of ELA
The correlation of pain relief with changes in uterine contractility and maternal-fetal hemodynamics
From the enrollment up to 120 minutes after the administration of ELA
Study Arms (1)
Patients in Labor
The study aims to recruit 200 patients in spontaneous or induced labor at 37-42 weeks of gestation, requesting the epidural labor analgesia (ELA) and meeting the inclusion criteria.
Interventions
The eligible patients will have their vital signs (blood pressure, saturation, heart rate) and the Doppler velocities in the uterine arteries, umbilical artery and the fetal middle cerebral artery measured directly before the administration of ELA. They will be also asked to rate their level of pain on the visual analogue scale (VAS). The specific method and drug regimen for ELA will be determined by the attending anesthesiologist. The mode of administration (continuous infusion, intermittent bolus, or patient-controlled epidural analgesia) will be recorded along with the anesthetic agents used for future subgroup analysis. The vital signs, the Doppler velocities and VAS score will be recorded after 30, 60 and 120 minutes. After 2 hours the patients will be examined to assess the progress of labor.
Eligibility Criteria
The patient in labor admitted to the Clinical Department of Obstetrics and Perinatology at the National Medical Institute of the Ministry of the Interior and Administration in Warsaw, Poland and meeting the inclusion criteria.
You may qualify if:
- ≥ 18 years old
- singleton pregnancy
- signed informed consent form
- patients in labor
- cervical dilation ≥ 3cm,
- patient requesting and eligible for epidural analgesia
- normal CTG trace for at least 30 minutes before epidural analgesia
You may not qualify if:
- \< than 18 years old
- preterm delivery
- labor induced or stimulated by oxytocin
- multiple pregnancy
- fetal malformations
- \< than 3cm cervical dilation
- lack of CTG trace for at least 30 minutes before epidural analgesia
- patient not requesting or not eligible for epidural analgesia
- informed consent form not signed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinical Department of Obstetrics and Perinatology at the National Medical Institute of the Ministry of the Interior and Administration
Warsaw, 02-507, Poland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 25, 2025
First Posted
March 6, 2025
Study Start
March 17, 2025
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
March 6, 2025
Record last verified: 2025-02